JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org. This content downloaded from 142.51.This article presents a detailed typological analysis of the locally produced Mycenaean IIIC:1 pottery assemblages from Tel Miqne-Ekron and Ashdod. Various aspects of the decoration and technology of this pottery group are examined, along with its stratigraphic context, regional distribution, and subsequent development. This synthesis of the initial phase of the Philistine ceramic corpus allows us to establish firm typological links between this assemblage and the Late Helladic IIIC Early and earlier part of the Late Helladic IIIC Middle periods in the Aegean, and with the transitional Late Cypriote IIC/IIIA and Late Cypriote IIIA periods on Cyprus. In absolute terms, we propose a date during the second quarter of the 12th century B.C.E. for the beginning of Philistine settlement on the southern Coastal Plain of Israel. The typology, chronology, and regional distribution of Mycenaean IIIC:1 pottery refute the notion that it was produced as a substitution for the Late Bronze Age Aegean imports. In addition, the identification of the stylistic development of this ware in Philistia, paralleled in the Aegean and eastern Mediterranean, indicates continued contacts between the two regions in the first half of the 12th century B.C.E.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.